Early Access — free while we kick the tires
EdgarHawk

Purcell Michael J.

Director

Director

Latest: Director buying · April 2026

1 filing analyzed · 1 company · Latest 2026-04-27

Companies

Company Buys Sells Direction
Hepion Pharmaceuticals, Inc. HEPA 1 0 Net buying

Activity

April 2026
high
Buy
1,250,000 shares
$50,000
Significance 6/10

Director Michael J. Purcell purchases 1,250,000 shares of HEPA at $0.04; cluster pattern with 3 other insiders buying in past 14 days.

Director Michael J. Purcell acquired 1,250,000 shares at $0.04 on 2026-04-21, with a post-transaction holding of 1,250,000 shares (zero prior position). This buy occurs within a cluster pattern: 3 other insiders also purchased within the past 14 days, suggesting coordinated or simultaneous conviction at the $0.04 price level. The company is materially distressed—latest quarterly revenue was $0.00, net income was $-472,506.00, and market cap stands at only $697,219.02—yet the multi-insider purchase activity signals potential board-level or management alignment at depressed valuations. The stock trades at $0.06 currently, 50% above the transaction price, though it remains -84.6% from its 52-week high of $0.39, indicating severe deterioration from prior levels.

Related insiders

Create a free account

Build watchlists, get email alerts on the tickers you follow, and read the full AI analysis on every insider filing.

Sign up — free during early access